Mothers’ emotional states and attitudes regarding their children with asthma

Objectives: The aim of this study was to investigate the associations of asthma with the psychological profile (depression and anxiety) of children with asthma and their mothers as well as the attitudes of these mothers toward their children and their family relationships. Methods: Sixty-four children with asthma, 60 healthy children and their mothers were included in the study. The Children’s Depression Inventory (CDI) and Childhood Anxiety Sensitivity Index (CASI) were applied to the children. All mothers completed the Beck Depression Inventory, the State-Trait Anxiety Inventory, the Parental Attitude Research Instrument and the Family Assessment Device. Results: CASI scores were significantly higher in children with asthma (p?<?0.001) than in healthy children. The increasing duration and severity of asthma were associated with increasing anxiety levels in children with asthma. Depression and anxiety scores were significantly higher in the mothers of children with asthma than in the comparison group. The mothers of children with asthma did not have supportive and friendly relationships with their children. In addition, these mothers had significantly higher Attitude of Hostility and Rejection, Attitude of Over-parenting and Authoritarian Attitude scores than those of the comparison group. Increasing duration and severity of asthma influenced family functions and the attitude of the mothers of children with asthma. There was a correlation between an increasing number of emergency department visits and increasing depression in the mothers of children with asthma. Conclusions: This cross-sectional study revealed that the disease may negatively affect the lives of children with asthma and their mothers and their family relationships.     

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials

BackgroundAt ketamine and esketamine doses at which antidepressant doses are achieved, these agents are relatively selective, noncompetitive, N-methyl-D-aspartate receptor antagonists. However, at substantially higher doses, ketamine has shown mu-opioid receptor (MOR–gene symbol: OPRM1) agonist effects. Preliminary clinical studies showed conflicting results on whether naltrexone, a MOR antagonist, blocks the antidepressant action of ketamine. We examined drug-induced or endogenous MOR involvement in the antidepressant and dissociative responses to esketamine by assessing the effects of a functional single nucleotide polymorphism rs1799971 (A118G) of OPRM1, which is known to alter MOR agonist-mediated responses.MethodsParticipants with treatment-resistant depression from 2 phase III, double-blind, controlled trials of esketamine (or placebo) nasal spray plus an oral antidepressant were genotyped for rs1799971. Participants received the experimental agents twice weekly for 4 weeks. Antidepressant responses were rated using the change in Montgomery–Åsberg Depression Rating Scale (MADRS) score on days 2 and 28 post-dose initiation, and dissociative side effects were assessed using the Clinician-Administered Dissociative-States Scale at 40 minutes post-dose on days 1 and 25.ResultsIn the esketamine + antidepressant arm, no significant genotype effect of single nucleotide polymorphism rs1799971 (A118G) on MADRS score reductions was detected on either day 2 or 28. By contrast, in the antidepressant + placebo arm, there was a significant genotype effect on MADRS score reductions on day 2 and a nonsignificant trend on day 28 towards an improvement in depression symptoms in G-allele carriers. No significant genotype effects on dissociative responses were detected.ConclusionsVariation in rs1799971 (A118G) did not affect the antidepressant response to esketamine + antidepressant. Antidepressant response to antidepressant + placebo was increased in G-allele carriers, compatible with previous reports that release of endorphins/enkephalins may play a role in mediating placebo effect.Trial Registration{"type":"clinical-trial","attrs":{"text":"NCT02417064","term_id":"NCT02417064"}}NCT02417064 and {"type":"clinical-trial","attrs":{"text":"NCT02418585","term_id":"NCT02418585"}}NCT02418585; www.clinicaltrials.gov     

卒中后抑郁病因机制研究进展

目前我国已是世界上脑卒中风险最大的国家。卒中后抑郁(Post-Stroke Depression,PSD)是脑卒中后最常见的神经精神并发症之一。PSD不仅延长患者功能康复时间,严重影响生活质量,而且显著增加致残率和病死率,给家庭、社会带来沉重负担、负面引导等不良影响。虽然目前证实神经递质、神经内分泌、神经解剖、炎症因子、遗传基因、神经营养因子、氧化应激、肠道菌群、社会心理等与PSD密切相关,但对PSD的具体病因机制尚无统一定论,给疾病的预防和治疗带来严峻考验。     

浅谈肝俞龙虎交战针法为主治疗排卵障碍性不孕

结合中医理论及外界影响因素分析认为,排卵障碍性不孕以"肝气郁结、疏泄失调"为病机,治则立"疏肝解郁、调畅气机"为大法,探讨治疗该病选用肝俞施用龙虎交战针法的理论依据。为针灸治疗排卵障碍性不孕提供新的思路及方法,同时也体现了古典针法创新性的运用。     

手术室心理护理对手术患者精神状态的影响

目的探讨手术室心理护理对手术患者焦虑、抑郁状态及护理满意度的影响。方法以医院2017年1月—2019年4月在医院接受手术治疗的1200例患者展开研究,随机将其划分为研究组(n=600)与对照组(n=600),分别接受常规基础上的心理护理以及单纯常规护理,对比分析患者抑郁、焦虑评分、护理满意度。结果治疗后,与对照组比,观察组抑郁、焦虑评分均更低;且研究组(97.0%)患者护理满意度高于对照组(83.7%),差异有统计学意义(P<0.05)。结论心理护理干预对于手术患者精神干预结果比较好,不仅可以改善患者的抑郁、焦虑情况,也能提升其护理满意度。     

自我效能感在女性尿失禁患者中社会支持与抑郁之间的调节作用

目的 探讨自我效能感在女性尿失禁患者社会支持与抑郁之间调节作用,为降低尿失禁患者的抑郁水平提供参考。方法 选取2016年9月1日—2018年12月31日期间在三门峡市中心医院妇科诊断为尿失禁的患者作为本次的研究对象进行问卷调查,调查内容包括社会人口学资料、抑郁自评量表、一般自我效能感量表以及领悟社会支持评定量表等。结果 225例研究对象中,检出抑郁症状72例(32.0%),高龄、病程长、肥胖、离婚和丧偶、有抑郁家族史的患者抑郁检出率更高,差异有统计学意义(P<0.05);抑郁平均得分48.38.2,领悟社会支持平均得分为59.58.7,自我效能感平均得分为22.16.3;领悟社会支持(β=-0.251,P=0.002)和自我效能感(β=-0.324,P<0.001)对抑郁均呈负向作用,P<0.001),自我效能感在尿失禁患者社会支持与抑郁之间的关系中存在增强型调节作用(β=-0.114,P=0.020)。结论 女性尿失禁患者中抑郁检出率高,在提高其社会支持的前提下,同时提高自我效能,可进一步降低患者抑郁水平。     

柴胡加龙骨牡蛎汤联合腹针治疗脑卒中后抑郁疗效观察

目的:观察柴胡加龙骨牡蛎汤联合腹针治疗脑卒中后抑郁的临床疗效。方法:将94例失眠患者随机分为对照组和治疗组各47例,对照组采用氟哌噻吨美利曲辛片治疗,治疗组采用柴胡加龙骨牡蛎汤联合腹针治疗,两组均连续治疗6周后判定临床疗效,比较两组患者治疗前后汉密尔顿抑郁量表(HAMD)评分及Barthel指数(BI)变化。结果:两组患者治疗后HAMD评分较本组治疗前明显降低(P<0.05),BI评分较治疗前明显升高(P<0.05),且治疗组治疗后HAMD评分低于对照组(P<0.05),BI评分高于对照组(P<0.05)。两组患者治疗后中医证候积分与治疗前比较,差异有统计学意义(P<0.05);两组患者中医证候积分差值比较,差异有统计学意义(P<0.05)。结论:柴胡加龙骨牡蛎汤联合腹针治疗脑卒中后抑郁可改善患者抑郁症状。     

Vasogenic edema versus neuroplasticity as neural correlates of hippocampal volume increase following electroconvulsive therapy

BackgroundVolume increases of the hippocampus after electroconvulsive therapy (ECT) are a robust finding, pointing into the direction of neurogenesis. However, such volumetric increases could also be explained by edema and/or neuroplastic changes (such as angiogenesis).ObjectivesIf edema explains the volume increase of the hippocampus we hypothesize it would lead to increased mean diffusivity (MD). If neuroplastic would explain the volume increase, it would lead to decreased MD. To investigate angiogenesis as explanation we studied the perfusion fraction f and the pseudodiffusion component D1 obtained from intravoxel incoherent motion (IVIM) data, and relative perfusion changes obtained from arterial spin labelling (ASL) data.MethodsUsing ultra-high field (7 tesla) MRI we acquired IVIM and ASL data. We compared MD, f, D1 and ASL values for both hippocampi in 21 patients (before and after 10 ECT sessions) and 8 healthy controls (without ECT) in a linear mixed model adjusting for age and gender.ResultsWe found a significant decrease in MD (which was absent in the healthy controls) in the left and right hippocampus (t = -3.98, p < 0.001). In addition, a decrease in f (t = -4.61, p < 0.001, but not in controls) and no differences in D1 or ASL perfusion values (both p > 0.05) were found.ConclusionsThe decrease in MD in perfusion fraction f suggest that formation of edema nor angiogenesis are responsible for the ECT-induced volume increases in the hippocampus. Also, it supports the hypothesis that hippocampal volume increases might be due to neuroplastic changes.